Empagliflozin Doesn ' t Up Risk of Bone Fractures
FRIDAY, July 20, 2018 -- Empagliflozin does not increase the risk of bone fracture in patients with type 2 diabetes, according to a study published online June 15 in Diabetes Care.
Sven Kohler, M.D., from Boehringer Ingelheim International in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Jardiance | Orthopaedics | Pharmaceuticals | Study